As the Medtech industry evolves, companies pursue new strategies to create shareholder value

By James Woods, US Deals Principal The medical technology industry has enjoyed a period of exceptional performance over the last …

New revenue recognition rules will alter your deals: Is your team ready?

By John Toriello, PwC Deals Partner and Howard Friedman, PwC Deals Partner By now, almost all Finance executives understand they’re facing a deadline …

Align tax planning with strategy to unlock shareholder value

PwC’s stratified forecasting framework solves valuation challenges It may be 2017, but many companies still handle tax planning like they did years ago. Those …

Staying focused on solid valuation strategy in a field of unicorns

By Chad Morrissey, PwC Deals Partner “Are we in a bubble? Are today’s tech companies overvalued? Is higher better?” These are questions I hear over …

Related Links


Bob Saada

US Deals Leader Tel: +1 (646) 471-7219 Email:

Neil Dhar

Tel: +1 (646) 471-3700 Email: